Diseases, Conditions, Syndromes

New treatment principle for chronic hepatitis B and D infections

A new immunological treatment against hepatitis B and D viruses, both of which can cause liver cancer, shows promising results in animal models. Results from the treatment, which is being developed by researchers at Karolinska ...

Diseases, Conditions, Syndromes

Malaria vaccine shows promise: study

An experimental malaria vaccine tested on children in Burkina Faso has shown "a high level of efficacy" in protecting against the disease, a study published in the United States said Wednesday.

Diseases, Conditions, Syndromes

Push to cure hepatitis B, a neglected disease

A coalition of researchers, health organisations and patient groups on Wednesday launched an ambitious campaign to cure hepatitis B, a disease that kills twice as many people as malaria but gets far less attention.

Medications

Clinical trial of malaria vaccine begins in Africa

The vaccine, RTS,S, developed by GlaxoSmithKline (GSK) Biologicals and PATH Malaria Vaccine Initiative (MVI), is currently in phase III clinical trials and has previously reduced episodes of malaria in infants and young children ...

Pediatrics

What vaccines does my child need by age 18 months?

Have you ever wondered why babies get vaccines starting from the day they're born? One big reason: The youngest are most at risk of diseases. It's also the time in your child's development that their immune system learns ...

Diseases, Conditions, Syndromes

Androgen boosts hepatitis B virus replication

Androgen enhances replication of hepatitis B virus (HBV), rendering males more vulnerable than females to this virus, according to research published in the February Journal of Virology.

Medical research

Shark compound proves potential as drug to treat human viruses

A compound initially isolated from sharks shows potential as a unique broad-spectrum human antiviral agent, according to a study led by a Georgetown University Medical Center investigator and reported in the Proceedings of ...

Oncology & Cancer

European studies on risks of hepatocellular carcinoma

Among known risk factors for hepatocellular cancer, smoking, obesity, and heavy alcohol consumption, along with chronic hepatitis B and C infection, contribute to a large share of the disease burden in Europe, according to ...

Medications

Discovery of a restriction factor for hepatitis B virus

Hepatitis B is a viral liver infection that can lead to acute or chronic conditions. Although there is a vaccine that offers protection against the virus, current treatments which prevent the virus from replicating are not ...

page 3 from 16